NVDA:NASDAQNVIDIA Corporation Analysis
Data as of 2026-08-23 - not real-time
$214.72
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
NVIDIA Corporation is priced at $214.72 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it gained 1.8%. Momentum indicators put RSI at 51.0 (neutral) with MACD reading bearish. The recent range runs from support at $190.01 up to resistance at $227.92.
Multiples put this in fair territory: 32.9 times earnings against the sector's 35.2. Consensus targets land 41.9% above where the shares trade now. Revenue is growing at 85.2% on a 63.0% profit margin. The 0.47% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 37.6%, a beta of 1.88 and a maximum drawdown of 20.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
Multiples put this in fair territory: 32.9 times earnings against the sector's 35.2. Consensus targets land 41.9% above where the shares trade now. Revenue is growing at 85.2% on a 63.0% profit margin. The 0.47% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 37.6%, a beta of 1.88 and a maximum drawdown of 20.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
Top Market Events
Space Exploration Technologies Corp. NASDAQ:SPCX beat Wall StreetNvidia NASDAQ: NVDA shareholders holding 100 shares of the firm are expected to receive $25 when the company’s next...The problem with AI valuations is that infrastructure spending is running far ahead of the revenue available to support...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 195.29
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 32.9 versus sector average of 35.2
- Trading above the 200-day average of 195.29
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 32.9 versus sector average of 35.2
- Analyst targets imply +41.9% versus the current price
- Profit margin of 63.0% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth85.20%
Profit Margin62.97%
P/E Ratio32.9
ROE114.29%
ROA52.73%
Debt/Equity6.55
P/B Ratio26.6
Op. Cash Flow$125.6B
Free Cash Flow$46.3B
Industry P/E35.2
Technical Analysis
TrendBullish
RSI51.0
Support$190.01
Resistance$227.92
MA 20$213.18
MA 50$207.58
MA 200$195.29
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair Value$68.48
Target Price$304.73
Upside/Downside41.92%
GradeFair
TypeGrowth
Dividend Yield0.47%
Risk Assessment
Beta1.88
Volatility37.65%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.